Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Porcine Patch Repairs Soft Tissues

By HospiMedica staff writers
Posted on 12 Jan 2007
A new soft tissue repair product can be used in various procedures involving soft tissue repair and reinforcement. More...


The ProPatch soft tissue repair matrix was developed from bovine pericardial tissue and is used to reinforce weakened soft tissues. It provides a resorbable scaffold that is replaced by the patient's own soft tissue. Indications for use include vaginal prolapse and reconstruction of the pelvic floor, abdominal and chest wall repair, muscle flap reinforcement, and rectal prolapse. The ProPatch can also be used to reinforce tissues repaired by sutures or by suture anchors during tendon repair surgeries, such as reinforcement of the rotator cuff, patellar, Achilles, biceps, quadriceps, or other tendons. The Propatch is a product of CryoLife (Kennesaw, GA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"ProPatch provides an effective alternative to the products available for soft tissue repair,” said Steven G. Anderson, president and CEO of CryoLife. "The indications for its use are broad and varied, particularly for hernia repairs in which the use of a natural tissue product, such as ProPatch, is preferred.”

Since synthetic meshes are prone to erosion, there is a current trend moving towards porcine xenogenic meshes, which consist of an acellular collagen matrix with a high tensile strength.



Related Links:
CryoLife

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.